Mark Fletcher, See Remarks at GENEREX BIOTECHNOLOGY CORP (GNBT), bought 20,000 shares at $0.24 ($5K) on 2011-04-06, disclosed to the SEC on 2011-04-07.
Open-market purchase of $5k GNBT by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| GNBT | BUY | 2009-01-12 | $4K | — | Filing → |
| GNBT | BUY | 2008-11-03 | $9K | — | Filing → |
| GNBT | SELL | 2008-04-21 | $263K | — | Filing → |